Market Research Logo

Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis

Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis

Get 10% Free Customization in this Report

Adult Vaccines Market is expected to be close to US$ 20 Billion by the year 2022. Because of vaccines, some diseases (like Polio and Diphtheria) are becoming rare. Vaccination can prevent certain deadly diseases in all age groups. Almost all countries around the world have introduced efficient National Immunization Programme in their vaccination schedule to overcome the epidemics caused by vaccine-preventable diseases. WHO’s Global Vaccine Action Plan, Global Immunization Vision and Strategy (GIVS), The GAVI Alliance all are putting their best to minimize the incidence of vaccine-preventable diseases which indeed is driving the adult vaccine market vigorously.


Influenza Vaccine Leads the Adult Vaccine Market for the Year 2017

Influenza vaccine is dominating the adult vaccine segment in year 2017, however it will lose its place to Pneumococcal vaccine in the coming future as admissions for pneumonia had almost tripled over the last 15 years. Other than Influenza and Pneumococcal Vaccines, Cervical Cancer (HPV), Hepatitis and Travel vaccines also have considerable market share in adult vaccines market.


Considerable Growth in Immunization of Cervical Cancer (HPV), Zoster, Meningococcal, Hepatitis, Tdap and MMRV Vaccines

In terms of Immunization; Influenza holds the maximum share as influenza vaccination is recommended to take annually in almost all countries of the world. However, with the growing awareness and efficiency of vaccines in preventing diseases, our analysis found that there will be considerably growth in the number for people opting for Cervical Cancer (HPV), Zoster, Meningococcal, Hepatitis, Tdap and MMRV vaccines in future till 2022.

Administration of Vaccines Doses

Influenza Vaccine holds the topmost place while talking about the administration of vaccine doses as influenza strains change every year and people needs to get an updated influenza shot each year to stay protected. Expect Influenza; Cervical Cancer (HPV), Pneumococcal and Hepatitis vaccines have remarkable administration doses.

Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis is the 2nd publication by Renub Research on Adult Vaccines Market. This 181 pages research report with 77 Figures and 32 Tables provides a complete analysis of Adult Vaccines Market, Immunization Numbers in People, Number of Vaccine Doses Administered in Adults (Disease wise) & Key Players Analysis.

Adult Vaccines in the Report have been studied from 3 Viewpoints

1. Global Adult Vaccines (Disease wise) Market & Forecast (2011 – 2022)
2. People Immunized (Disease wise) & Forecast (2011 – 2022)
3. Doses of Vaccines Administered (Disease wise) & Forecast (2011 – 2022)

9 Vaccines Studied in the Report are as Follows:

1. Influenza
2. Cervical Cancer
3. Zoster (Shingles)
4. MMRV (Measles, Mumps, Rubella and Varicella)
5. Pneumonia
6. Meningitis
7. Hepatitis
8. DTap (Diphtheria, Tetanus, Pertussis)
9. Travel & Miscellaneous Vaccine

Companies Vaccines Sales and Forecast

1. GlaxoSmithKline, plc Sales & Forecast (2011 – 2022)
2. Merck & Co. Sales & Forecast (2011 – 2022)
3. Sanofi Pasteur’s Sales & Forecast (2011 – 2022)
4. Pfizer, Inc.’s Sales & Forecast (2011 – 2022)
5. Others Vaccines


Key Questions Answered In This Report

• What will be the Market Size of Global Adult Vaccine by the year 2022?
• What are the Key Drivers & Challenges for Adult Vaccines Market?
• Who are the key players in Adult Vaccine Market?
• What products are in key Players Pipeline?


  • Research Findings
  • Global - Adult Vaccines Market and Forecast
    • Table Vaccine Recommendations
    • Table Other Recommended Vaccines
  • Global - Adult Vaccines Market Share and Forecast
    • Table Worldwide - Adult Vaccines Market Share (Percent), 2011 - 2016
    • Table Worldwide - Adult Vaccines Market Share (Percent), 2017 - 2022
  • Worldwide - Adult Immunized Numbers and Forecast
  • Worldwide - Adult Immunized Share and Forecast
    • Table Worldwide - Adult Immunized Share (Percent), 2011 - 2016
    • Table Worldwide - Forecast for Adult Immunized Share (Percent), 2017 - 2022
  • Worldwide - Doses of Adult Vaccines Administered and Forecast
  • Worldwide - Doses of Vaccines Administered to Adult Share and Forecast
    • Table Worldwide - Doses of Vaccines Administered to Adult Share (Percent), 2011 - 2016
    • Table Worldwide - Forecast for Doses of Vaccines Administered to Adult Share (Percent), 2017 - 2022
  • Worldwide - Vaccine Companies Market Share and Forecast
  • Disease wise - Adult Vaccines Market and Forecast
    • Influenza - Adult Vaccines Market and Forecast
    • Cervical Cancer (HPV) - Vaccines Market and Forecast
    • Zoster (Shingles) - Vaccines Market and Forecast
    • MMRV (Measles, Mumps, Rubella, and Varicella Vaccine) - Adult Vaccines Market and Forecast
    • Pneumococcal - Adult Vaccines Market and Forecast
    • Meningococcal - Adult Vaccines Market and Forecast
    • Hepatitis - Adult Vaccines Market and Forecast
    • TdaP - Adult Vaccines Market and Forecast
    • Travel and Miscellaneous - Vaccines Market and Forecast
  • Disease wise - Adult Immunized Numbers and
    • Influenza - Number of Adults Immunized and Forecast
    • Cervical Cancer (HPV) - People Immunized and Forecast
    • Zoster (Shingles) - Number of People Immunized and Forecast
    • MMRV - Number of Adults Immunized and Forecast
    • Pneumococcal - Number of Adults Immunized and Forecast
    • Meningococcal - Number of Adults Immunized and Forecast
    • Hepatitis - Number of Adults Immunized and Forecast
    • TdaP - Number of Adults Immunized and Forecast
  • Disease wise - Doses of Vaccines Administered and
    • Influenza - Doses of Adult Vaccines Administered and Forecast
    • Cervical Cancer (HPV) - Doses of Vaccines Administered and Forecast
    • Zoster (Shingles) - Doses of Vaccines Administered and Forecast
    • MMRV - Doses of Adult Vaccines Administered and Forecast
    • Pneumococcal - Doses of Adult Vaccines Administered and Forecast
    • Meningococcal - Doses of Adult Vaccines Administered and Forecast
    • Hepatitis - Doses of Adult Vaccines Administered and Forecast
    • TdaP - Doses of Adult Vaccines Administered and Forecast
  • Disease wise - Immunization Profile
    • Immunization Coverage (%) in Infants (2005 - 2015)
    • Global Immunization Profile (2011 - 2015)
      • Table Worldwide - Number of Reported Cases, 2011 - 2015
    • Regional Immunization Profile (2001 - 2015)
      • Measles - Number of Cases Reported
        • Table Measles - Number of Cases Reported, 2001 - 2015
      • Mumps - Number of Cases Reported
        • Table Mumps - Number of Cases Reported, 2001 - 2015
      • Rubella - Number of Cases Reported
        • Table Rubella - Number of Cases Reported, 2001 - 2015
      • Rubella (CRS) - Number of Cases Reported
        • Table Rubella (CRS) - Number of Cases Reported, 2001 - 2015
      • Diphtheria - Number of Cases Reported
        • Table Diphtheria - Number of Cases Reported, 2001 - 2015
      • Tetanus (Neonatal) - Number of Cases Reported
        • Table Tetanus (Neonatal) - Number of Cases Reported, 2001 - 2015
      • Tetanus (Total) - Number of Cases Reported
        • Table Tetanus (Total) - Number of Cases Reported, 2001 - 2015
      • Pertussis - Number of Cases Reported
        • Table Pertussis - Number of Cases Reported, 2001 - 2015
      • Polio - Number of Cases Reported
        • Table Polio - Number of Cases Reported, 2001 - 2015
      • Yellow Fever - Number of Cases Reported
        • Table Yellow Fever - Number of Cases Reported, 2001 - 2015
      • Japanese encephalitis - Number of Cases Reported, 2006 - 2015
        • Table Japanese encephalitis - Number of Cases Reported, 2006 - 2015
  • Vaccines Key Players Sales and Forecast
    • GlaxoSmithKline, plc.'s Vaccines Sales and Forecast
    • Merck & Co. Vaccines Sales and Forecast
    • Sanofi Pasteur's (France) Vaccines Sales and Forecast
    • Pfizer, Inc.'s Vaccines Sales and Forecast
    • Others Vaccines Sales and Forecast
  • Vaccines - Products and Pipeline
    • GSK Vaccine Product Pipeline
    • Merck Vaccine Product Pipeline
      • Table Merck Vaccine Product Pipeline
    • Sanofi Vaccine Product Pipeline
      • Table Sanofi Vaccine Product Pipeline
    • Pfizer Vaccine Product Pipeline
      • Table Pfizer Vaccine Product Pipeline
  • Top Mergers and Acquisitions in the Vaccine Industry
    • Table Vaccine Mergers & Acquisitions
  • Vaccines and Regulator's Interventions
    • Making and Meeting Standards of Quality and Safety
    • Vaccine Funding
  • Vaccine Market Drivers
    • Inclusion in National Immunization Schedule
      • Table United States Immunization Schedule
      • Table Afghanistan Immunization Schedule
      • Table Norway Immunization Schedule
      • Table India Immunization Schedule
      • Table Vietnam Immunization Schedule
    • Growing Immunization Coverage for HPV Vaccines
    • Increase in Prevalence of Infectious Diseases
    • Global Immunization Vision and Strategy (GIVS)
    • GAVI Model Fuelling Vaccine Manufacturers
      • The Partnership Model
      • The Business Model
    • Increasing Vaccine Availability in United States
    • The Vaccine Safety Data link Project
    • The Vaccine Injury Compensation Program
    • Transforming of Vaccine Technologies
    • Global Vaccine Action Plan by WHO (2011 - 2020)
      • Table Worldwide - Total Future Deaths Averted through Vaccination (Million), 2011 - 2020
      • Table Goal-Level Indicators, 2015 & 2020
    • Continuous Focus on Effective Communication Strategies
      • Table Improvement Strategies or Requirements - the Joint Commission and the Project's Collaborating Organizations
  • Vaccines Market Challenges
    • Hurdles to Optimal use of Licensed Vaccines
      • Technical Obstacles
      • Economic Obstacles
      • Cultural Obstacles
    • Complexity of Vaccine Development & Approval System Thwarts Product Development
      • Legal Obstacles
      • General Technical Barriers
      • Economic Barriers
      • Regulatory Barriers
    • Shortening the Timeline for Vaccine Development
    • Refusal/Resistance to Vaccination
      • Vaccine Adverse Event Reporting System
    • Vaccine Shortages and Delays
    • Obstacles in Vaccine Research & Development
    • Barriers to New Entrants in the Vaccines Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report